© 2019 by Molecular Decisions

  • Facebook Social Icon
  • LinkedIn Social Icon
 

THE SCIENCE

We measure proteins and their modification using a nano-proteomic immunoassay (NIA).   

We can measure direct biological effects on growth, death, and immune activation.

Our assays are highly sensitive (2 pgs, 4 nls, 25 cells) quantitative and reproducible (< 2% variation).

PUBLICATIONS

1.  Alice C. Fan, Jennifer J. O’Rourke, Dave R. Praharaj, and Dean W. Felsher

 

Real-Time Nanoscale Proteomic Analysis of the Novel Multi-Kinase Pathway Inhibitor Rigosertib to Measure the Response to Treatment of Cancer

Expert Opin Investig Drugs. 2013

Pdf free access: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111569/pdf/nihms591324.pdf

 

2.  Mahesh Seetharam, Alice C. Fan, Mai Tran, Liwen Xu, John P. Renschler, Dean W. Felsher, Kunju Sridhar, Francois Wilhelm, Peter L. Greenberg,

 

Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na

 

Leukemia Research 2012;

Pdf free access: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612532/pdf/nihms442015.pdf

 

3.  Ronan T. Swords, Ronan T. Swords, Peter L. Greenberg, Andrew H. Wei, Simon Durrant, Anjali S. Advani, Mark S. Hertzberg, Ian D. Lewis, Gabriel Rivera, Dita Gratzinger, Alice C. Fan, Dean W. Felsher, Jorge E. Cortes, Justin M. Watts, Geoff T. Yarranton, Jackie M. Walling, Jeffrey E. Lancet,

 

KB004, a first in class monoclonal antibody targeting the receptortyrosine kinase EphA3, in patients with advanced hematologicmalignancies: Results from a phase 1 study.

 

Leukemia Research 2016;

Abstract:http://www.lrjournal.com/article/S0145-2126(16)30198-9/abstract

4.  Alice C Fan, Debabrita Deb-Basu, Mathias W Orban, Jason R Gotlib, Yasodha Natkunam, Roger O’Neill, Rose-Ann Padua, Liwen Xu, Daryl Taketa, Amy E Shirer, Shelly Beer, Ada X Yee, David W Voehringer & Dean W Felsher

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens

Nature Medicine 2009

Abstract: http://www.nature.com/nm/journal/v15/n5/full/nm.1903.html

 

5.  Brian A. DeChristopher, Alice C. Fan, Dean W. Felsher, Paul A. Wender

 

“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo

Oncotarget, January, 2012

Pdf free access:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292892/pdf/oncotarget-03-058.pdf